U.S. Authorises Experimental Ebola Treatment Amid Kenya Quarantine Resistance

Author: kenyans.co.kePublished on: June 5, 2026Country: Kenya
HealthWorld / International
U.S. Authorises Experimental Ebola Treatment Amid Kenya Quarantine Resistance

The United States has authorized the experimental use of the MBP-134 antibody treatment for Ebola for high-risk individuals amid the Central Africa outbreak. Meanwhile, a planned 50-bed quarantine facility in Laikipia, Kenya, has sparked local protests. US and Kenyan authorities insist the facility is safe and part of a health security partnership.

Stay informed with NewsBoulevard

Get the latest news summaries delivered to your inbox

Related News

Stay Updated with NewsBoulevard

Subscribe to our newsletter for the latest news summaries delivered to your inbox

Learn more